We report on the results of a prospective screening trial using abbreviated breast MRI with ultrafast dynamic contrast-enhanced imaging (3.5 seconds per time point) to screen for breast cancer in 166 women at any risk of developing breast cancer. The cancer detection rate was 24.1 per 1000 women while maintaining a specificity of 97.6%. The biopsy recommendation and abnormal interpretation rates were lower than in other published trials that did not include ultrafast imaging in their abbreviated protocol.
No takes yet. Share an insight, caveat, or question.
Pineda et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: